Overview

Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Status:
Recruiting

Trial end date:
2023-09-30

Target enrollment:

Participant gender:

Summary

This is a double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of Goofice® in patients with chronic constipation.

Phase:

Phase 3

Details

Lead Sponsor:

Synmosa Biopharma Corp.